Re: Neal D. Shore, Fred Saad, Michael S. Cookson, et al. Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer. N Engl J Med 2020;382:2187-96

Journal article

Peer reviewed

Brandon A Mahal, Anthony V D'Amico and Paul L Nguyen

European urology, Vol.78(5), pp.e195-e195

2020-11

PMID: 32863056

Abstract

Androgens

Androgen Antagonists

Humans

Pyrimidinones

Male

Phenylurea Compounds

Prostatic Neoplasms - drug therapy

7 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.147 Prostate Cancer; 1.147.97 Prostate Cancer
Web Of Science research areas: Urology & Nephrology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Re: Neal D. Shore, Fred Saad, Michael S. Cookson, et al. Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer. N Engl J Med 2020;382:2187-96
Creators: Brandon A Mahal - University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center. Electronic address: bmahal@med.miami.edu
Anthony V D'Amico - Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA, USA
Paul L Nguyen - Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA, USA
Publication Details: European urology, Vol.78(5), pp.e195-e195
Academic Unit: Miller School of Medicine; UMMG Dept of Radiation Oncology
Language: English
Resource Type: Journal article
PMID: 32863056
Record Identifier: 991031597591302976